About the Juvenile Idiopathic Arthritis Working Group
Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disease of childhood and a cause of acquired disability. Multiple outcome measurement sets are currently used in studies of JIA.
Since 2015, the OMERACT JIA Core Set Working Group has obtained global stakeholder input from patients with JIA, caregivers, healthcare providers (HCP), and researchers to update the JIA Core Domain Set
Alessandro Consolaro
Co-Chair
Esi Morgan, MD, MSCE
Co-Chair
Jane Munro
Co-Chair
Erin Balay-Dustrude, MD
Fellow
Ben Horgan
Patient Research Partner
Jennifer Horonjeff
Patient Research Partner
OMERACT Endorsed Core Domain Set for Juvenile Idiopathic Arthritis
JIA OVERVIEW VIDEO
RECENT WORKING GROUP PUBLICATIONS
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group
Establishing an updated core domain set for clinical trials and longitudinal studies in juvenile idiopathic arthritis: a report from the OMERACT 13 JIA Workshop
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016